These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12849986)

  • 1. Mutations within a conserved protein kinase A recognition sequence confer temperature-sensitive and partially defective activities onto mouse c-Rel.
    Gapuzan ME; Pitoc GA; Gilmore TD
    Biochem Biophys Res Commun; 2003 Jul; 307(1):92-9. PubMed ID: 12849986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
    Mosialos G; Gilmore TD
    Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discreet mutations from c-Rel to v-Rel alter kappaB DNA recognition, IkappaBalpha binding, and dimerization: implications for v-Rel oncogenicity.
    Phelps CB; Ghosh G
    Oncogene; 2004 Feb; 23(6):1229-38. PubMed ID: 14961076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
    Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
    Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel.
    Mosialos G; Hamer P; Capobianco AJ; Laursen RA; Gilmore TD
    Mol Cell Biol; 1991 Dec; 11(12):5867-77. PubMed ID: 1944267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature-sensitive transforming mutants of the v-rel oncogene.
    White DW; Gilmore TD
    J Virol; 1993 Nov; 67(11):6876-81. PubMed ID: 8411392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the v-Rel dimerization interface reveals a critical role for v-Rel homodimers in transformation.
    Liss AS; Bose HR
    J Virol; 2002 May; 76(10):4928-39. PubMed ID: 11967310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of NF-kappaB in the marine fish Stenotomus chrysops and examination of its activation by aryl hydrocarbon receptor agonists.
    Schlezinger JJ; Blickarz CE; Mann KK; Doerre S; Stegeman JJ
    Chem Biol Interact; 2000 May; 126(2):137-57. PubMed ID: 10862814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activation.
    Sanjabi S; Williams KJ; Saccani S; Zhou L; Hoffmann A; Ghosh G; Gerondakis S; Natoli G; Smale ST
    Genes Dev; 2005 Sep; 19(18):2138-51. PubMed ID: 16166378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.
    White DW; Pitoc GA; Gilmore TD
    Mol Cell Biol; 1996 Mar; 16(3):1169-78. PubMed ID: 8622661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages.
    Sanjabi S; Hoffmann A; Liou HC; Baltimore D; Smale ST
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12705-10. PubMed ID: 11058167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-ray crystal structure of proto-oncogene product c-Rel bound to the CD28 response element of IL-2.
    Huang DB; Chen YQ; Ruetsche M; Phelps CB; Ghosh G
    Structure; 2001 Aug; 9(8):669-78. PubMed ID: 11587641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three mutations in v-Rel render it resistant to cleavage by cell-death protease caspase-3.
    Barkett M; Dooher JE; Lemonnier L; Simmons L; Scarpati JN; Wang Y; Gilmore TD
    Biochim Biophys Acta; 2001 Apr; 1526(1):25-36. PubMed ID: 11287119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein beta (C/EBP beta) and Rel p50.
    Agrawal A; Cha-Molstad H; Samols D; Kushner I
    J Immunol; 2001 Feb; 166(4):2378-84. PubMed ID: 11160296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in kappaB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein.
    Nehyba J; Hrdlicková R; Bose HR
    Oncogene; 1997 Jun; 14(24):2881-97. PubMed ID: 9205096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A yeast transcription assay defines distinct rel and dorsal DNA recognition sequences.
    Kamens J; Brent R
    New Biol; 1991 Oct; 3(10):1005-13. PubMed ID: 1768648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of c-Rel transcriptional activity by PKA catalytic subunit beta.
    Yu SH; Chiang WC; Shih HM; Wu KJ
    J Mol Med (Berl); 2004 Sep; 82(9):621-8. PubMed ID: 15197457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional conservation of Rel binding sites in drosophilid genomes.
    Copley RR; Totrov M; Linnell J; Field S; Ragoussis J; Udalova IA
    Genome Res; 2007 Sep; 17(9):1327-35. PubMed ID: 17785540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutant Rel-homology domain promotes transcription by p50/NFkappaB1.
    Xu X; Gélinas C
    Oncogene; 1997 Apr; 14(13):1521-30. PubMed ID: 9129142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-specific association and shuttling of IkappaBalpha provides a mechanism for nuclear NF-kappaB in B lymphocytes.
    Tam WF; Wang W; Sen R
    Mol Cell Biol; 2001 Jul; 21(14):4837-46. PubMed ID: 11416157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.